Alpha-linolenic acid and the risk of prostate cancer. What is the evidence?

J Urol. 2004 Apr;171(4):1402-7. doi: 10.1097/01.ju.0000116544.09581.55.

Abstract

Purpose: Several studies have examined the association between polyunsaturated fatty acids and prostate cancer risk. We evaluated the evidence on the association between the essential polyunsaturated fatty acid, known as alpha-linolenic acid, and the risk of prostate cancer in humans.

Materials and methods: We comprehensively reviewed published studies on the association between alpha-linolenic acid and the risk of prostate cancer using MEDLINE.

Results: A number of studies have shown a positive association between dietary, plasma or red blood cell levels of alpha-linolenic acid and prostate cancer. Other studies have demonstrated either no association or a negative association. The limitations of these studies include the assumption that dietary or plasma alpha-linolenic acid levels are positively associated with prostate tissue alpha-linolenic acid levels, and measurement errors of dietary, plasma and red blood cell alpha-linolenic acid levels.

Conclusions: More research is needed in this area before it can be concluded that there is an association between alpha-linolenic acid and prostate cancer.

Publication types

  • Review

MeSH terms

  • Biomedical Research
  • Fatty Acids, Unsaturated
  • Humans
  • Linoleic Acid*
  • Male
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / etiology*
  • Prostatic Neoplasms / pathology
  • Risk Factors

Substances

  • Fatty Acids, Unsaturated
  • Linoleic Acid